Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Biotech Jim who wrote (11437)	12/21/2017 12:51:12 PM
From: Miljenko Zuanic	Read Replies (2) \| Respond to of 12215

I am not talking about difference in companies (we all know what is what), I am interested in COMPOUND activity difference, if any (also similarity) are there? Yes, trials execution and data for 3196 are very strong and 2809 will hardly be close (IMO, direct translation from P1b data), but....there is always room for surprise, IF one can find one (which I am looking for)? 0214 and 2809 are Metabasis molecules: < 1.73 “ TR-Beta Compounds ” means Metabasis’ MB07811 and MB10866 compounds, and any other compounds comprised by the TR-Beta Patents, and any salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers, polymorphs, and derivatives of such compounds. The TR-Beta Compounds include those compounds listed on S CHEDULE 1 hereto under the heading “TR-Beta Compounds” (which is correct as of the Effective Date).> VKTX S1 file